RE: What value CAR-T?7 Jul 2021 15:18
I cannot remember JHFH telling anyone to buy.
JHFH is simply a holder / poster who is well researched and passionate about the opportunity with Hemo
No more, no less.....
We've all understand the risks of investing in a preclinical Biotech
The best thing about the drop and dilution in Share Price is that buying or holding Hemo is much less of a risk that it was when it sat 10-15p with no funding in place.
Everyone should do their own research and make their own mind up. but for me, this represents an incredible investment opportunity for the medium and long term. (and maybe even the short term, as news could drop at any time)